Related Experiment Video
Updated: May 31, 2026

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs
Tencho Tenev1, Katiuscia Bianchi, Maurice Darding
1The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK. tencho.tenev@icr.ac.uk
Abstract:
A better understanding of the mechanisms through which anticancer drugs exert their effects is essential to improve combination therapies. While studying how genotoxic stress kills cancer cells, we discovered a large ∼2MDa cell death-inducing platform, referred to as "Ripoptosome." It contains the core components RIP1, FADD, and caspase-8, and assembles in response to genotoxic stress-induced depletion of XIAP, cIAP1 and cIAP2. Importantly, it forms independently of TNF, CD95L/FASL, TRAIL, death-receptors, and mitochondrial pathways. It also forms upon Smac-mimetic (SM) treatment without involvement of autocrine TNF. Ripoptosome assembly requires RIP1's kinase activity and can stimulate caspase-8-mediated apoptosis as well as caspase-independent necrosis. It is negatively regulated by FLIP, cIAP1, cIAP2, and XIAP. Mechanistically, IAPs target components of this complex for ubiquitylation and inactivation. Moreover, we find that etoposide-stimulated Ripoptosome formation converts proinflammatory cytokines into prodeath signals. Together, our observations shed new light on fundamental mechanisms by which chemotherapeutics may kill cancer cells.
Insights
Scientists discovered the Ripoptosome, a large cell death platform crucial for anticancer drug efficacy. This complex forms under genotoxic stress, independent of known death pathways, and promotes cancer cell death.
Area of Science:
- Cell Biology
- Molecular Oncology
- Drug Discovery
Background:
- Understanding anticancer drug mechanisms is vital for improving combination therapies.
- Genotoxic stress is a key mechanism by which chemotherapeutics induce cancer cell death.
- The precise molecular platforms mediating stress-induced cell death remain incompletely defined.
Purpose of the Study:
- To identify and characterize novel cell death platforms involved in anticancer drug action.
- To elucidate the molecular composition and assembly requirements of the Ripoptosome.
- To investigate the role of the Ripoptosome in mediating cancer cell death upon genotoxic stress.
Main Methods:
- Cellular assays to detect and analyze large protein complexes.
- Biochemical analyses including immunoprecipitation and Western blotting.
- Studies involving genotoxic agents (e.g., etoposide) and Smac-mimetics.
Main Results:
- Discovery of a ~2MDa cell death-inducing platform, the Ripoptosome, containing RIP1, FADD, and caspase-8.
- Ripoptosome assembly is triggered by genotoxic stress-induced depletion of IAPs (XIAP, cIAP1, cIAP2).
- Formation occurs independently of TNF, death receptors, and mitochondrial pathways, and requires RIP1 kinase activity.
- The Ripoptosome mediates both apoptosis and necrosis and is negatively regulated by FLIP and IAPs.
- Etoposide-induced Ripoptosome formation converts inflammatory signals into pro-death signals.
Conclusions:
- The Ripoptosome represents a novel, fundamental cell death platform assembled under genotoxic stress.
- Its assembly and function provide new insights into how chemotherapeutics kill cancer cells.
- Targeting the Ripoptosome or its regulators could offer new strategies for cancer therapy.
Related Concept Videos
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Restarting Stalled Replication Forks
MAPK Signaling Cascades
DNA Damage can Stall the Cell Cycle

